HEK293 recombinant peptide representing the first 220 amino acids of CD44 binds to the four anti-44 mAbs when deglycosylated. by Daniel F. Lusche (10692753)

“…<p>A. Treatment of the HEK293 recombinant peptide, that represents amino acids 1–220 of CD44, with neuramidase and PNGaseF causes a decrease in molecular mass from approximately 60 to approximately 40 kDa (-), in the absence, (+) in the presence of neuramidase and PNGaseF. …”

Myopia Progression during the COVID-19 Era: A Systematic Review and Meta-analysis by Mohammad Javad Najafzadeh (8873153)

Scotopic a-wave characteristic in WT and <i>Fmr1</i> KO mice. by Rafaëlle Rossignol (621196)

“…For each (<b>A</b>) typical ERG obtained at light intensity −2.88 log(cd.s.m⁻²), the decreasing part of the a-wave is fitted to calculate the extrapolated (<b>B</b>) maximal a-wave amplitude (<i>A</i>_max) and (<b>C</b>) S</p><p>_A</p> parameter reflecting the photoreceptor sensitivity. …”

Predicted performance of a control program administered to dogs on arrival in US animal shelters. by Benjamin D. Dalziel (650353)

“…White lines show medians and shaded areas enclose the 5^th to the 95^th percentiles of the simulation data. (<b>B</b>) Decreasing control efficacy to 75% can still achieve eradication in isolated shelters (blue region, solid line), however shelters that transfer dogs amongst themselves at the observed mean rate of τ = 0.1 would preserve CIV in a few shelters despite the vaccination program (red region, dashed line). …”

Table 1_Efficacy and safety of sofosbuvir plus daclatasvir in hemodialysis patients with genotype 1b or 2a hepatitis C virus infection: a single-arm, prospective real-world study.x... by Kaili Wang (2246485)

“…Demographic characteristics revealed a mean age of 57.0 years, male predominance (75%), average dialysis duration of 7.0 years, and mean body weight of 63.0 kg. …”

Phenotypic characterization of HG-treated primary tubular cell cultures. by Barbara Torsello (4594873)

Flow diagram of participants selection. by Wei Huang (36889)

“…Each10 units increase in BRI, ASM/ BMI decreased by 29% (β = −0.29,95% CI: −0.31, −0.28, <i><i>p</i></i> value < 0.0001). …”

Minimal data set. by Wei Huang (36889)

“…Each10 units increase in BRI, ASM/ BMI decreased by 29% (β = −0.29,95% CI: −0.31, −0.28, <i><i>p</i></i> value < 0.0001). …”

Weighted comparison of baseline characteristics. by Wei Huang (36889)

“…Each10 units increase in BRI, ASM/ BMI decreased by 29% (β = −0.29,95% CI: −0.31, −0.28, <i><i>p</i></i> value < 0.0001). …”

Loss of FAT1 expression results in increased YAP/TAZ protein levels in MDA-MB-231 and U-87 cells. by Rui Li (4631)

Effect of MIB2 knock-down on YAP/TAZ protein levels and gene expression in MDA-MB-231 and U-87 cells. by Rui Li (4631)

Role of MIB2 in tumor cell growth <i>in vitro.</i> by Rui Li (4631)

Amelioration of spatial memory function following Withanolide A administration during hypoxic exposure. by Iswar Baitharu (414359)

“…<p>Exposure to hypobaric hypoxia increased (i) path length and (ii) latency during spatial memory test but decreased (iii) number of platform crossing and (iv) time spent in target quadrant during probe trial when was reversed following withanolide A supplementation before and during exposure to hypobaric hypoxia. …”

The interaction between tonic GABA_AR signaling and glutamatergic activity. by Michelle Day (11617621)

“…In the absence of NMDARs, a combination of onsite shunt and reduced AMPAR driving force arising from depolarization presumably underlies the GABA conductance density-dependent decrease in response. …”

Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy by Amanda H. Kahn-Kirby (5634986)

“…Cytoprotection was preceded by a dose-dependent decrease in general lipid oxidation and the specific 15-LO product 15-hydroxyeicosatetraenoic acid (15-HETE).…”

A Central Role for <i>GRB10</i> in Regulation of Islet Function in Man by Inga Prokopenko (43252)

“…<i>GRB10</i> knock-down in human pancreatic islets showed reduced insulin and glucagon secretion, which together with changes in insulin sensitivity may explain the paradoxical reduction of glucose despite a decrease in insulin secretion. Together, these findings suggest that tissue-specific methylation and possibly imprinting of <i>GRB10</i> can influence glucose metabolism and contribute to T2D pathogenesis. …”

T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab by Usha Bughani (4220698)

“…We previously demonstrated that Itolizumab, a CD6 domain 1 (CD6D1) specific humanized monoclonal antibody, inhibited the proliferation and cytokine production by T lymphocytes stimulated with anti-CD3 antibody or when co-stimulated with ALCAM. …”

One-step and multi-step growth curves each mutant and SVA-WT. by Hai-Fan Zhao (15990862)

ROS and Fe²⁺ levels in HT22 cells. by Lu Li (14069)

Overview of the sampling design. by Camille Leroux (18470820)